Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125609341 | 12560934 | 1 | I | 20160608 | 20160708 | 20160715 | 20160715 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201607002760 | ELI LILLY AND CO | 69.42 | YR | M | Y | 0.00000 | 20160715 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125609341 | 12560934 | 1 | PS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | 500 MG, UNKNOWN | Y | U | 21462 | 500 | MG | INJECTION | |||||
| 125609341 | 12560934 | 2 | SS | CARBOPLATIN HOSPIRA | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | UNK, UNKNOWN | U | 0 | |||||||||
| 125609341 | 12560934 | 3 | C | ASPIRINA | ASPIRIN | 1 | Y | 0 | |||||||||||
| 125609341 | 12560934 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Y | 0 | |||||||||||
| 125609341 | 12560934 | 5 | C | XGEVA | DENOSUMAB | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125609341 | 12560934 | 1 | Lung adenocarcinoma |
| 125609341 | 12560934 | 2 | Lung adenocarcinoma |
| 125609341 | 12560934 | 3 | Product used for unknown indication |
| 125609341 | 12560934 | 4 | Product used for unknown indication |
| 125609341 | 12560934 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125609341 | 12560934 | OT |
| 125609341 | 12560934 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125609341 | 12560934 | Decreased appetite | |
| 125609341 | 12560934 | General physical health deterioration | |
| 125609341 | 12560934 | Hepatocellular injury | |
| 125609341 | 12560934 | Malnutrition | |
| 125609341 | 12560934 | Off label use | |
| 125609341 | 12560934 | Pericardial effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125609341 | 12560934 | 1 | 20160601 | 20160601 | 0 | |
| 125609341 | 12560934 | 2 | 20160601 | 0 |